The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales
The govt has rolled out three schemes for promoting the manufacture of API
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
The company is confident of commencing production at both Mahad and Chiplun units soon
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
The company has predominantly built a portfolio into veterinary products
Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline
Revenues from operations for FY21 stood at Rs. 202.38 crore as compared to 167.27 crore, up by 21%
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Dr. Reddy's has the rights to distribute 250mn doses in India
Subscribe To Our Newsletter & Stay Updated
